Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hebbar

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|January 1, 1997
[Role of first-line palliative chemotherapy in metastatic colorectal cancer]M Hebbar
The International Journal of Biological Markers|April 14, 2000
Significance of soluble endothelial molecule E-selectin in patients with breast cancerM Hebbar, J P Peyrat
European Journal of Cancer Care|August 26, 2009
KRAS mutational status assessment in patients with metastatic colorectal cancer: are the clinical implications so clear?M Hebbar, P Fournier, O Romano
Leukemia & Lymphoma|September 1, 1992
The role of intensive chemotherapy in myelodysplastic syndromesP Fenaux, C Preudhomme, M Hebbar
La Revue De Medecine Interne|January 1, 1995
[Systemic diseases in myelodysplastic syndromes]M Hebbar, K Hebbar-Savéan, P Fenaux
La Revue De Medecine Interne|January 1, 1995
[Immunotherapy of malignant melanoma. New prospects]M Hebbar, L Vanlemmens, S Lecomte, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1994
[Pancreatic tuberculosis in systemic lupus]M Hebbar, D Gosset, P Y Hatron, et al.
La Revue De Medecine Interne|February 1, 1994
[Acute pancreatitis, systemic lupus and antiphospholipid syndrome. 2 cases]M Hebbar, D Gosset, P Y Hatron, et al.
Anticancer Research|July 25, 1998
Age as a prognostic factor in breast cancerL Vanlemmens, M Hebbar, J P Peyrat, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patientsF Revillion, M Hebbar, J Bonneterre, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|January 1, 1997
[Role of first-line palliative chemotherapy in metastatic colorectal cancer]M Hebbar
The International Journal of Biological Markers|April 14, 2000
Significance of soluble endothelial molecule E-selectin in patients with breast cancerM Hebbar, J P Peyrat
European Journal of Cancer Care|August 26, 2009
KRAS mutational status assessment in patients with metastatic colorectal cancer: are the clinical implications so clear?M Hebbar, P Fournier, O Romano
Leukemia & Lymphoma|September 1, 1992
The role of intensive chemotherapy in myelodysplastic syndromesP Fenaux, C Preudhomme, M Hebbar
La Revue De Medecine Interne|January 1, 1995
[Systemic diseases in myelodysplastic syndromes]M Hebbar, K Hebbar-Savéan, P Fenaux
La Revue De Medecine Interne|January 1, 1995
[Immunotherapy of malignant melanoma. New prospects]M Hebbar, L Vanlemmens, S Lecomte, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1994
[Pancreatic tuberculosis in systemic lupus]M Hebbar, D Gosset, P Y Hatron, et al.
La Revue De Medecine Interne|February 1, 1994
[Acute pancreatitis, systemic lupus and antiphospholipid syndrome. 2 cases]M Hebbar, D Gosset, P Y Hatron, et al.
Anticancer Research|July 25, 1998
Age as a prognostic factor in breast cancerL Vanlemmens, M Hebbar, J P Peyrat, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patientsF Revillion, M Hebbar, J Bonneterre, et al.
Pageof 8